Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Public ClinicalTrials.gov record NCT00487656. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin) decreases the number of people who die as a result of Disseminated Intravascular Coagulation (DIC) complication of sepsis.
Study identification
- NCT ID
- NCT00487656
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 750 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Apr 30, 2010
- Completion
- Jul 31, 2010
- Last update posted
- May 17, 2011
2007 – 2010
United States locations
- U.S. sites
- 49
- U.S. states
- 20
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Tuscon | Arizona | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Colton | California | — | — |
| Not listed | Loma Linda | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Rancho Mirage | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | San Francisco | California | — | — |
| Not listed | Stanford | California | — | — |
| Not listed | Hartford | Connecticut | — | — |
| Not listed | Bay Pines | Florida | — | — |
| Not listed | Celebration | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Kansas City | Kansas | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Hazard | Kentucky | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Springfield | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Pontiac | Michigan | — | — |
| Not listed | Camden | New Jersey | — | — |
| Not listed | Englewood | New Jersey | — | — |
| Not listed | Newark | New Jersey | — | — |
| Not listed | Flushing | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Fayetteville | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Danville | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lackland Air Force Base | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00487656, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2011 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00487656 live on ClinicalTrials.gov.